With Great Power Comes Great Responsibility: Ethical Dilemmas at the Top

Yeah, I know I stole the line from a Spider-Man comic!  But, recently an issue came up on one of the national committees I’m a part of, and it got me wondering about this issue. We all know which TV news stations have a Republican or Democratic slant.  Similarly, cardio



Is the United States Different?

Is there something special about the United States?



Is it Worth Doing the Most Important Trials? Yes and No

Back when I was a medical student, resident and then fellow I was taught that evidence-based medicine carried the solution to all medical conundrums. If we didn’t know which treatment is better, why not do a well-constructed clinical trial to figure it out?



Interventional Heart Failure – Has Its Time Come?

Believe it or not, I initially went into cardiology to treat heart failure. In fact, as a medical student at Brown University, I spent all my free time traveling to and working at Mount Sinai Medical Center, under the tutelage of Drs.



Medicine: Balancing Science and Art

Medical school was tough. Not so much because we were learning how to care for patients, but that we were learning the minutia of the human body. The sheer amount of detail that goes into understanding physiology, anatomy, and how all the organ systems interrelate in disease is, to say the least, intense and often intimidating. Yet, we all learn the science and through it all we learn that a thorough understanding of this science can make you a great Doctor. Why? Because you may find the answer that someone else missed, solely because your knowledge base was superior.



First Look: CLOSURE Trial Preliminary Results

As someone who performs a good number of PFO closures in those believed to be at high-risk of recurrent cryptogenic stroke despite medical therapy, I was certainly interested in hearing preliminary results from the CLOSURE trial released a few weeks ago. Initiated in 2003, during the fledgling days of closure technology and expertise, the study randomized patients with cryptogenic stroke and PFO to closure using the StarFlex device (NMT Medical) versus best medical therapy, the latter comprising full dose aspirin or warfarin at physician discretion.

The study failed to meet its primary endp



Calling All Leaders: SCAI’s Emerging Leader Mentorship Program

Back when I was a fellow, my mentors were physicians who masterfully waded through the seas of clinical care, research and education, always able to remain focused on all three visions simultaneously. Historically, such physicians set the benchmark for academic excellence and national leadership. Somewhat naively, I set about my career firmly intent on following in their esteemed footsteps, hoping to make my own contribution to the field.

But how does one do this? I quickly learned that planning an academic career is not as easy as one may think, and the biggest lesson of all was that yo



Revisiting the Gold Standard

Recently, an article came out in the New England Journal of Medicine that got some people talking. The article, entitled “Low Diagnostic Yield of Elective Coronary Angiography”[1], certainly gave the impression that such procedures are unwarranted in the vast majority of patients. But, let’s take a closer look.

The authors used the NCDR database to evaluate patients without a definite indication for coronary angiography. This limited the evaluation to about 20% of all procedures. Not surprisingly, over 80% of them had some sort of noninvasive evaluation for ischemia prior to p



PFO and Cryptogenic Stroke: Finding Closure

There’s no denying the impact of stroke. Not only is it the third leading cause of death, but it is in many ways more feared than heart disease or cancer. As interventionists, our sights have turned to three controversial procedures: (1) carotid stenting, (2) left atrial appendage isolation, and (3) PFO closure. While the first two concern older patients, the third affects those younger and often in the prime of life, throwing patient and physician fears and preferences into the debate. The argument for PFO closure goes something like this: (1) patients with cryptogenic stroke, especi



Cardiology is a Team Sport

In patient care, we all know the best outcomes come with teamwork. A team approach achieves the best care by drawing upon the unique strength of each member to form the ultimate authority or “single voice of action.”

Recently I had an 84 year-old patient with Hypertrophic Cardiomyopathy (HCM) who suffered cardiogenic syncope while driving. I made a tough decision to have my colleague implant an ICD for secondary prevention. Unfortunately, she developed pericardial tamponade, requiring echocardiography, pericardiocentesis, and surgical intervention the next morning for ongoing bleedi